PD-L1 (6C8) Monoclonal Antibody
- Size: 100ul
- Application: WB, FCM
- Reactivity: Human
- Predicted Reactivity:
-
Datasheet Tech Support
IMAGES
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
PD-L1 (6C8) Monoclonal Antibody |
CONJUGATION |
Unconjugated |
HOST |
Rabbit |
SOURCE |
Recombinant human PD-L1 extracellular domain |
IMMUNOGEN RANGE |
|
CLONALITY |
Monoclonal |
ISOTYPE |
IgG |
CONCENTRATION |
Not Determined |
PURIFICATION |
Purified by Protein A. |
STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
STORAGE CONDITION |
Store for 1 year at -20°C from date of shipment. Store for 1 year at -20°C from date of shipment. |
TARGET |
|
---|---|
GENE ID |
|
SUBCELLULAR LOCATION |
|
SYNONYMS |
Programmed cell death 1 ligand 1; CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1; Programmed death ligand 1 |
BACKGROUND |
Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed:11015443). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (PubMed:28813417, PubMed:28813410). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed:10581077). |
APPLICATION DILUTION |
WB(1:300-1000), FCM(1:20-100) |